News
TOI
3.560
-2.47%
-0.090
Weekly Report: what happened at TOI last week (1222-1226)?
Weekly Report · 12/29/2025 10:21
Weekly Report: what happened at TOI last week (1215-1219)?
Weekly Report · 12/22/2025 10:20
The Oncology Institute: Making Progress
Seeking Alpha · 12/18/2025 20:48
Biotech Momentum Carries After-Hours Trading Gains
NASDAQ · 12/18/2025 04:15
Oncology Institute Director Makes Significant Stock Sale!
TipRanks · 12/17/2025 02:08
Weekly Report: what happened at TOI last week (1208-1212)?
Weekly Report · 12/15/2025 10:28
Weekly Report: what happened at TOI last week (1201-1205)?
Weekly Report · 12/08/2025 10:26
Oncology Institute management to meet with B. Riley
TipRanks · 12/03/2025 16:25
Oncology Institute Announces Board Member Resignation
TipRanks · 12/01/2025 22:04
Oncology Institute management to meet with B. Riley
TipRanks · 12/01/2025 14:55
Oncology Institute director Gabe Ling resigns
TipRanks · 12/01/2025 13:40
The Oncology Institute Board Member Gabe Ling Resigns
Reuters · 12/01/2025 13:30
THE ONCOLOGY INSTITUTE ANNOUNCES RESIGNATION OF BOARD MEMBER GABE LING
Reuters · 12/01/2025 13:30
Press Release: The Oncology Institute Announces Resignation of Board Member Gabe Ling
Dow Jones · 12/01/2025 13:30
Weekly Report: what happened at TOI last week (1124-1128)?
Weekly Report · 12/01/2025 10:22
ONCOLOGY INSTITUTE INC <TOI.O>: NEEDHAM INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $5
Reuters · 11/25/2025 12:15
Oncology Institute Initiated at Buy by Needham
Dow Jones · 11/25/2025 11:46
Oncology Institute Price Target Announced at $5.00/Share by Needham
Dow Jones · 11/25/2025 11:46
Oncology Institute’s Strategic Position and Growth Potential in Value-Based Care Transition
TipRanks · 11/25/2025 11:37
Needham Initiates Coverage On Oncology Institute with Buy Rating, Announces Price Target of $5
Benzinga · 11/25/2025 11:36
More
Webull provides a variety of real-time TOI stock news. You can receive the latest news about The Oncology Institute Inc through multiple platforms. This information may help you make smarter investment decisions.
About TOI
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.